• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[关于在内淋巴途径给药抗生素以预防脓毒症患者治疗期间肠道微生物群易位的临床生理学验证]

[The clinico-physiological validation of the use of the endolymphatic route for antibiotic administration for preventing the translocation of intestinal microflora during the treatment of sepsis patients].

作者信息

Maksimenko V I, Treshchinskiĭ A I, Shlapak I P, Vasil'ev G A, Bondar' M V, Kharchenko L A, Iakub A A

出版信息

Lik Sprava. 1992 Jul(7):56-61.

PMID:1448990
Abstract

One of the main mechanisms of generalization of infection in purulent-inflammatory processes of the abdominal cavity, retroperitoneal space and pelvis minor is translocation of the pathogenic microflora of the intestine in the lymphatic system via regional lymphatic nodes with subsequent rupture into the systemic circulation. Endolymphatic administration of antibacterial agents into the peripheral lymphatic vessel favours saturation of the reticuloendothelial structures of the lymph nodes by the antibiotic agent that increases their barrier function and, thus, prevents generalization of the infection and development of polyorganic insufficiency.

摘要

腹腔、腹膜后间隙及小骨盆化脓性炎症过程中感染扩散的主要机制之一是肠道致病微生物通过区域淋巴结在淋巴系统中移位,随后破入体循环。经外周淋巴管内淋巴途径给予抗菌药物有利于抗生素使淋巴结的网状内皮结构饱和,从而增强其屏障功能,进而防止感染扩散及多器官功能不全的发生。

相似文献

1
[The clinico-physiological validation of the use of the endolymphatic route for antibiotic administration for preventing the translocation of intestinal microflora during the treatment of sepsis patients].[关于在内淋巴途径给药抗生素以预防脓毒症患者治疗期间肠道微生物群易位的临床生理学验证]
Lik Sprava. 1992 Jul(7):56-61.
2
[Experience with the use of endolymphatic antibacterial therapy].[内淋巴抗菌治疗的应用经验]
Klin Khir (1962). 1989(4):48-50.
3
[Administration of medications via a lymphatic vessel in the treatment of diffuse peritonitis and sepsis].[通过淋巴管给药治疗弥漫性腹膜炎和败血症]
Vestn Khir Im I I Grek. 1985 Jan;134(1):68-70.
4
[Experimental study of a new method of endolymphatic antibiotic administration and a trial of its clinical use].[内淋巴给药新方法的实验研究及其临床应用试验]
Antibiotiki. 1980 May;25(5):375-81.
5
[Pharmacokinetics of gentamicin after its regional endolymphatic and lymphotropic administration to dogs].庆大霉素经局部内淋巴和淋巴趋向性给药于犬后的药代动力学
Antibiot Khimioter. 1991 Jan;36(1):32-4.
6
[Endolymphatic antibiotic therapy of inflammatory infiltrates of the abdominal cavity].
Sov Med. 1984(12):34-6.
7
[Direct controlled endolymphatic antibiotic therapy in the combined treatment of sepsis].[直接控制内淋巴抗生素疗法在脓毒症联合治疗中的应用]
Klin Khir (1962). 1988(3):27-30.
8
[Endolymphatic antibiotic administration in the combined treatment of peritonitis].[内淋巴途径抗生素给药在腹膜炎联合治疗中的应用]
Vestn Khir Im I I Grek. 1982 May;128(5):6-10.
9
[Indirect endolymphatic antibiotic therapy in suppurative-inflammatory diseases in children].[儿童化脓性炎症性疾病的间接内淋巴抗生素治疗]
Klin Khir (1962). 1991(6):71.
10
[The endolymphatic therapy of patients with suppurative cholangitis (1)].
Lik Sprava. 1993 Jul(7):63-6.